Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rnastar
    Member
    • Aug 2013
    • 13

    #1

    Quick Interpretation of FastQC output

    Dear all,

    I have attached a plot of the average per-base quality of reads in my sample.

    It appears that surprisingly the 5' ends of my reads have lower quality on average than the 3' end.

    Is this indicative of the fact that I need to trim my reads on the 5' end? There does not appear to be any detected adapter contamination. Any thoughts?

    Thank you!
    Attached Files
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Nothing to worry about. This looks like a very typical of illumina run. There should be no need to trim from 5'-end.

    Comment

    • rnastar
      Member
      • Aug 2013
      • 13

      #3
      Thanks! Any idea on why we see the drop off in quality on the 5' end, or what could be causing it?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        It would be technically correct to call it a drop-off .. if you compare it to the rest of the plot. But you are still above Q30 for all bases which is excellent quality data.

        As RTA ramps up in the first 10-12 cycles it is calculating different metrics (color matrix, phasing etc).

        Comment

        • FWOS
          Epigenomics NGS Beast
          • Oct 2010
          • 17

          #5
          All Illumina HiSeq reads start out lower. Mostly this is improved after template generation (cycle 4). This is partially due to lower quality bases that result from the prep process, and it is also partially do do with how the per-base sequence quality is assessed. Once template generation is complete and the phasing / pre phasing data are taken into account the overall Q scores should hover above Q30 until the read length becomes a factor on per base sequence quality.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...